1 Coronary Artery Disease Flashcards

1
Q

Chronic Coronary Disease

  • ___ angina / ___ ischemic heart disease
  • post ___ or revascularization
  • angina with coronary artery ___ / microvascular angina
A
  • stable/stable
  • ACS
  • spasm
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Acute Coronary Syndromes

  • ___ angina
  • non ___ segment elevation MI
  • ___ segment elevation MI
A
  • unstable
  • ST
  • ST
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Clinical Syndromes of Chronic Coronary Disease

  • Stable angina pectoris: ___ disease
  • Post-ACS; post-revascularization
  • variant or Prinzmetal angina: ___ disease
  • cardiac syndrome X: ___ disease
  • silent myocardial ___
A
  • macrovascular
  • vasospastic
  • microvascular
  • ischemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Myocardial Ischemia - Oxygen Supply/Demand Imbalance

1) fixed ___ , vaso ___ , thrombus
2) decreased coronary ___
3) ischemia
4) angina

A

1) stenosis, spasm
2) bloodflow

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Myocardial Ischemia - Oxygen Supply/Demand Imbalance

1) increased ___ , contractility, afterload, preload
2) increased oxygen ___
3) ischemia
4) angina

A

1) HR
2) consumption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Factors Impacting Myocardial O2 Supply/Demand Ratio

  • Contractility - decrease will ___ O2 consumption
  • HR - decrease will ___ O2 consumption and ___ coronary perfusion
  • Preload-LVEDV - ___ by venodilation, decrease leads to ___ in O2 consumption, decrease leads to ___ in myocardial perfusion
  • Afterload - ___ by dilation of arteries, decrease leads to ___ in O2 consumption
A

Contractility - decrease

HR - decrease, increase

Preload-LVEDV - decreaased,
decrease, increase

Afterload - decreased, decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Epicardial Vessels

1, 2, 3: ___
11: ___
12, 13, 14: ___
18,19: ___

A

RCA = right coronary artery
LM = left main
LAD = left anterior
LCX = left circumflex

LAD = “widow maker”

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Pathophysiology of Stable Angina

Myocardial ischemia
- imbalance between myocardial oxygen ___ and ___
- usually secondary to increased myocardial work ( ___ induced) in the setting of a fixed decrease in myocardial oxygen ___
- produces disturbances in myocardial function without causing myocardial ___

A
  • supply, demand
  • effort, supply
  • necrosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Stable Angina Pectoris

___ discomfort in the chest/other areas

caused by myocarridal ___ and assocaited with a disturbance in function without ___

___ characterisitics of anginal episodes

A
  • substernal
  • ischemia, necrosis
  • unchanging
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Clinical Presentation: PQRST

  • Precipitating factors: ___
  • Palliative measures: ___ and/or ___
  • Quality and quantity of pain: squeezing, heaviness, tightening
  • Region and radiation: ___
  • Severity of the pain: subjective > 5/10
  • Timing and temporal pattern: lasts < ___ min, usually relieved in 5-10 min
A
  • exertion
  • rest, SL NTG
  • substernal
  • 20 min
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Classic Clinical Characteristics

ECG findings
- ___ segment depression (during ___)
- ___ segment elevation in variant ___

A
  • ST, ischemia
  • ST, angina
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Diagnostic Procedures for CHD - Exercise Tolerance Testing

  • treadmill or bicycle exercise testing
  • endpoints: duration, workload achieved, ECG changes, BP and HR responses, Sxs
  • double product: ___ x ___ is used as an index of MVO2
  • assessment of drug therapy - ___ and ___ may complicate interpretation by decreaseing HR
A
  • HR x SBP
  • beta blockers, CCBs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Diagnostic Procedures for CHD

Cardiac Imaging
- pharmacologic stress testing ( ___ )
- nuclear imaging
- electron beam computerized tomography (EBCT)
- calcium score (contraversial)

Echocardiography

Cardiac catheterization and coronary angiography
- definitive assessment of coronary anatomy
- invasive
- most ___ medical procedure in the US

A
  • Dobutamine
  • common
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Question 1

A

A

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment of CCD

desired outcome 1
- risk factor modification
- prevent ___ and ___

desired outcome 2
- management of ___ episodes
- alleviate acute Sxs and prevent recurrent Sxs of ___

A
  • ACS, death
  • anginal
  • ischemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Treatment Algorithm - Risk Factor Modification

1) LSM
2) ___ vaccine
3) management of comorbidities - HTN: BP goal of less than or equal to ___ mmHg, DM: A1c less than or equal to ___ % , moderate to ___ intensity statins
4) antiplatelet therapy - ASA ___ mg daily OR ___ 75 mg daily if allergy
5) ___ - if HTN, DM, LVEF < 40%, or CKD OR ARB if intolerant

A
  • flu
  • 130/80, 7, high
  • 81, clopidogrel
  • ACEi
17
Q

Treatment Algorithm - Management of Angina

1) ___ - for acute attacks
2) Vasospastic angina? yes: BP < 130/80, add ___ , BP > 130/80, add ___, no: HR > 60 bpm: add ___ or ___
3) Angina symptoms controlled? yes: continue therapy and monitor, no…
4) BP < 130/80? yes: add ___ or ___ , no: add ___
5) continued angina? consider ___ or ___ surgery

A
  • SL NTG
  • LA nitrate, CCB
  • beta-blocker, Non-DHP CCB
  • ranolazine, LA nitrate
  • DHP CCB
  • PCI, CABG
18
Q

Other Risk Factor Modifications

A
  • influenza vaccination
  • alcohol consumption
  • exposure to air pollution
  • management of psychological factors
19
Q

Pharmacotherapy

Stable Angina/Ischemic Heart Disease, Post-ACS, or revascularization (5)

A

1) anti-platelet therapy
2) statin therapy
3) ACEi/ARB
4) colchicine?
5) beta-blockers

20
Q

ASA: Platelet COX-1 inhibition

acetylation and ___ inactiation of COX-1

antiplatelet activity: blocking ___ synthesis
- interferes with platelet ___
- prolongs ___ time
- blocks arterial ___ formation

high doses of ASA also inhibit COX-2

A

irreversible
TXA2
- aggregation
- bleeding
- thrombi

21
Q

COX-1 vs COX-2

COX-1 produces ___, which promotes ___ , increases platelet ___ , and vaso ___ occurs
- ASA prevents platelet ___

COX-2 produces ___ which has protective ___ effect, inhibits platelet ___, and vaso ____ occurs
- coxibs have higher ___ risk

high doses of ASA also inhibit COX-2

A

TXA2, clotting, aggregation, vasoconstriction
- aggregation

PGI2, anti-coagulative, aggregation, vasodilation
- thrombotic

22
Q

Anti-platelet Therapy - ASA (solube or EC)

  • Loading Dose: ___ - ___ mg
  • Dose: ___ - ___ mg daily
  • MOA: (low dose) - ___ inhibitis COX-1, blocking production of ___
  • ASA is detrimental at higher doses bc it also inhbits COX-2, which blocks ___
A
  • 162-325
  • 75-162
  • irreverisbly, TXA2
  • PGI2
23
Q

Anti-platelet Therapy - P2Y12i

clopidogrel ( ___ )
Loading Dose: ___ - ___ mg
Dose: ___ mg
MOA: ___ inhibit adenosine diphosphate induced platelet aggregation with no direct effect on ___

A

Plavix
300-600
75
selectively, TXA2

24
Q

Anti-platelet Therapy - P2Y12i

prasugrel ( ___ )
Loading Dose: ___ mg
Dose: ___ mg
MOA: ___ inhibit adenosine diphosphate induced platelet aggregation with no direct effect on ___
- indicated following ___

A

Effient
60
10
selectively, TXA2
ACS

25
Q

Anti-platelet Therapy - P2Y12i

ticagrelor ( ___ )
Loading Dose: ___ mg
Dose: ___ mg BID
MOA: ___ inhibit adenosine diphosphate induced platelet aggregation with no direct effect on ___
- indicated following ___ or prior ___

A

Brilinta
180
90
selectively, TXA2
ACS, MI

26
Q

Anti-platelet Therapy - P2Y12i

cangrelor ( ___ )
___ only
MOA: ___ inhibit adenosine diphosphate induced platelet aggregation with no direct effect on ___
- indicated following ___

A

Kengreal
IV
selectively, TXA2
ACS

27
Q

AE: ASA

  • GI: ___
  • Hematologic: ___ and ___ bleeding
  • Hypersensitivity
  • major bleeding 2-3% in year 1
A

bleeding
intracranial, extracranial

28
Q

If pt calls you thinking that they have a heart attack, instruct them to take ___ with their NTG. If they have the ec kind, tell them to ___ because it won’t dissolve until 4 hours later

A
  • ASA
  • chew